Literature DB >> 9405663

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

J S Boyle1, A Silva, J L Brady, A M Lew.   

Abstract

Immunizations of mice with plasmid DNAs encoding ovalbumin (OVA), human Ig, and hen egg lysozyme were compared with doses of soluble protein (without adjuvant) that induced similar IgG responses. The route of immunization influenced the magnitude of the antibody (Ab) response in that intradermal (i.d.) injection elicited higher IgG Ab levels than i.m. injection in both DNA- and protein-immunized mice. Although total IgG levels were similar to soluble protein controls, the avidity of the anti-OVA Abs generated by DNA immunization were 100- and 1,000-fold higher via the i.m. or i.d. route, respectively. However, despite the generation of high-avidity Ab in DNA-immunized mice, germinal centers could not be detected in either DNA- or protein-immunized mice. Examination of the IgG subclass response showed that IgG2a was induced by i.m. DNA immunization, coinciding with elevated interferon gamma production, whereas a dominant and elevated IgG1 response, coinciding with detectable interleukin 4 production, was generated after i.d. immunization with DNA or soluble OVA and hen egg lysozyme but not human Ig protein. As expected, cytotoxic T cell (CTL) responses could be detected only after DNA immunization. I.d. immunization produced the strongest CTL responses early (2 weeks) but was similar to i.m. later. Therefore, DNA immunization can differ from protein immunization by its ability to induce rapid CTL responses and higher avidity Ab, both of which are advantageous for vaccination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405663      PMCID: PMC25074          DOI: 10.1073/pnas.94.26.14626

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

2.  Conditions affecting direct gene transfer into rodent muscle in vivo.

Authors:  J A Wolff; P Williams; G Acsadi; S Jiao; A Jani; W Chong
Journal:  Biotechniques       Date:  1991-10       Impact factor: 1.993

3.  Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene.

Authors:  M A Yankauckas; J E Morrow; S E Parker; A Abai; G H Rhodes; V J Dwarki; S H Gromkowski
Journal:  DNA Cell Biol       Date:  1993-11       Impact factor: 3.311

4.  DNA-based immunization by in vivo transfection of dendritic cells.

Authors:  C Condon; S C Watkins; C M Celluzzi; K Thompson; L D Falo
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

Review 5.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; M A Liu
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

6.  Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization.

Authors:  D M Feltquate; S Heaney; R G Webster; H L Robinson
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

7.  The role of antibody concentration and avidity in antiviral protection.

Authors:  M F Bachmann; U Kalinke; A Althage; G Freer; C Burkhart; H Roost; M Aguet; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

8.  Gene vaccination with naked plasmid DNA: mechanism of CTL priming.

Authors:  M Corr; D J Lee; D A Carson; H Tighe
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

9.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells.

Authors:  J Jacob; J Przylepa; C Miller; G Kelsoe
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  37 in total

1.  A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.

Authors:  G Deliyannis; J S Boyle; J L Brady; L E Brown; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Strategies for improving responses to DNA vaccines.

Authors:  J S Boyle; I G Barr; A M Lew
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

Review 3.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  A single buffer that universally serves both restriction digestion and loading.

Authors:  Alexandra J Corbett; Jamie L Brady; Andrew M Lew
Journal:  Mol Biotechnol       Date:  2002-05       Impact factor: 2.695

5.  Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.

Authors:  Bishnu P Nayak; Gangadhara Sailaja; Abdul M Jabbar
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity.

Authors:  Arno Hänninen; Nathan R Martinez; Gayle M Davey; William R Heath; Leonard C Harrison
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

7.  Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein.

Authors:  R Weiss; W W Leitner; S Scheiblhofer; D Chen; A Bernhaupt; S Mostböck; J Thalhamer; J A Lyon
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 8.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Antibody response to HER2 extracellular domain and subdomains in mouse following DNA immunization.

Authors:  Fateme Sadri-Ardalani; Mahdi Shabani; Mohammad Mehdi Amiri; Motahareh Bahadori; Shaghayegh Emami; Ali Reza Sarrafzadeh; Farzaneh Noutash-Haghighat; Mahmood Jeddi-Tehrani; Fazel Shokri
Journal:  Tumour Biol       Date:  2015-08-19

10.  Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.

Authors:  Chien-Hsiung Pan; Nitya Nair; Robert J Adams; M Christine Zink; Eun-Young Lee; Fernando P Polack; Manmohan Singh; Derek T O'Hagan; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.